Verification of the correct client identity and ABO/Rh blood type compatibility is the most critical safety step in the transfusion process. Administering blood to the wrong client or blood of an incompatible type is the leading cause of acute hemolytic transfusion reactions — potentially fatal events caused by antibody-mediated destruction of the transfused red blood cells. The dual verification process exists specifically to create a second human check on this information before the transfusion begins. The donation date (A) is relevant for blood bank inventory management but is not the nurse's primary verification responsibility at the bedside. The ordering provider's name (B) is on the prescription and should be confirmed, but does not prevent hemolytic reactions. The collection location (D) has no bearing on transfusion safety.

The nurse must remain at the bedside for the first 15 minutes of a blood transfusion — corresponding to approximately the first 50 mL infused at a standard initial rate — because this is the period during which severe, potentially fatal reactions such as acute hemolytic reactions are most likely to manifest. During this window, the client has the highest exposure to any incompatible blood, and early recognition is critical to minimizing harm. Five minutes (A) is insufficient to detect all early reactions. Waiting until 100 mL has infused (C) exposes the client to twice the volume of blood before the critical monitoring period concludes, significantly increasing risk if an incompatibility exists. Remaining for the entire transfusion (D) is not required for all clients and is not practical; periodic monitoring is appropriate after the initial critical period in stable clients.

Whenever a transfusion reaction is suspected, the nurse's first and non-negotiable action is to stop the transfusion immediately and disconnect the blood tubing from the IV catheter. The IV access is then maintained using 0.9% normal saline with entirely new tubing to prevent infusion of residual blood. This must happen before any other intervention because the reaction type cannot be definitively identified at the bedside — symptoms of a benign febrile non-hemolytic reaction and a life-threatening acute hemolytic reaction can appear similar in early stages. Stopping first and determining type afterward is the required protocol; doing the reverse risks catastrophic harm. Slowing the rate (A) is never appropriate when a reaction is suspected. Administering an antipyretic (B) treats a symptom while the causative agent continues to infuse. Applying a warm blanket (D) addresses comfort but does not stop the source of the problem.

Back pain (particularly low back or flank pain) is a hallmark symptom of an acute hemolytic transfusion reaction, and shortness of breath can indicate circulatory overload, anaphylaxis, or TRALI — all of which require immediate intervention. The client correctly understands that these are critical symptoms to report. Choice B requires further teaching: pruritus (itching) during a transfusion is never 'normal' — it can be an early sign of an allergic reaction and must be reported promptly so the nurse can assess severity and determine whether to continue the transfusion. Normalizing itching teaches the client to tolerate a potentially worsening symptom without reporting it. Blood pressure does not typically increase significantly during a transfusion (C); a significant rise can indicate circulatory overload and a drop can indicate hemolytic or anaphylactic reaction. A burning sensation at the IV site (D) could indicate infiltration or phlebitis and should also be reported, not expected.

Sudden, severe low back or flank pain is the hallmark symptom of an acute hemolytic transfusion reaction and the most specific clinical cue that distinguishes this life-threatening emergency from other reaction types. It results from complement activation and cytokine release triggered by the destruction of incompatible red blood cells, causing inflammation and pain in the lumbar region. No other transfusion reaction type characteristically produces this symptom. Tachycardia (C) and fever (D) are present across multiple reaction types including the more benign febrile non-hemolytic reaction, making them less specific. Tachypnea (A) is a secondary compensatory response to the hemodynamic instability and is also non-specific.

An acute hemolytic transfusion reaction caused by incompatible blood is a medical emergency that can rapidly progress to shock, acute kidney failure, and disseminated intravascular coagulation if not immediately addressed. Risk for injury related to incompatible blood is therefore the priority hypothesis — it encompasses the most immediate, life-threatening consequence of the current situation and drives the most urgent nursing actions. Ineffective airway clearance (A) is not the primary concern in this presentation; the client's airway is not currently compromised. Deficient fluid volume from GI bleeding (C) is part of this client's history but is not the active emergency; the hemodynamic instability is being caused by the transfusion reaction, not ongoing bleeding. Hyperthermia as a standard response (D) is an inappropriate hypothesis because it minimizes a life-threatening reaction as benign.

After stopping the transfusion, the nurse must maintain IV access with 0.9% normal saline using completely new tubing — not the existing blood administration set. This is critical for two reasons: it ensures residual blood remaining in the original tubing is not inadvertently infused into the client, and it maintains a patent IV line for the administration of emergency medications and fluids. Normal saline is the only compatible IV solution for this purpose. Slowing the rate and waiting (A) is incorrect — the transfusion has already been stopped and the plan of care must address what comes next, not reverse a completed decision. Administering a sedative (C) is inappropriate; restlessness is a symptom of hemodynamic compromise and masking it with sedation would obscure the clinical picture. The prone position (B) is contraindicated in a hemodynamically unstable client and does not address the underlying emergency.

The blood bag and all attached tubing must be preserved and returned to the blood bank intact following a suspected transfusion reaction. The blood bank will perform testing on the remaining blood product — including rechecking the crossmatch, blood type, and performing a direct antiglobulin test — to confirm whether an incompatibility occurred and identify its cause. This information is critical for patient safety, legal accountability, and blood bank quality processes. Additionally, a post-reaction urine specimen is typically collected to check for hemoglobinuria. Ambulation (B) is contraindicated for a hemodynamically unstable client. Disposing of the blood bag (C) would destroy the evidence needed for investigation and is a serious error. Increasing the infusion rate (D) is dangerous and directly contraindicated — the transfusion has been stopped due to a suspected reaction and must not be restarted without explicit PHCP orders after investigation.

Transfusion-Associated Circulatory Overload (TACO) occurs when the volume or rate of blood infusion exceeds the cardiovascular system's capacity to handle the increased preload. In a client with pre-existing heart failure and a compromised left ventricle, even a standard transfusion can precipitate acute pulmonary congestion. The triad of new cough, bibasilar crackles (from fluid accumulating in the alveoli), and a bounding pulse (from increased stroke volume and venous congestion) is the classic TACO presentation. This is the most common serious transfusion complication in elderly or cardiac-compromised clients. Acute hemolytic reaction (B) presents with flank pain, fever, and hypotension — not fluid overload signs. Febrile non-hemolytic reaction (C) presents with fever and chills without respiratory or fluid overload signs. Mild allergic reaction (D) presents with urticaria and localized pruritus.

Localized urticaria (hives) and a rash confined to one body area, without systemic symptoms such as throat tightening, bronchospasm, hypotension, or respiratory distress, are the hallmark presentation of a mild allergic reaction to plasma proteins in the donor blood. This is an IgE-mediated hypersensitivity response. Importantly, mild allergic reactions are the one category of transfusion reaction where some protocols permit the transfusion to be temporarily stopped, an antihistamine administered, and the transfusion cautiously restarted if symptoms fully resolve — in contrast to all other reaction types where permanent discontinuation is required. An acute hemolytic reaction (A) presents with flank pain, fever, and hemodynamic instability — not isolated skin findings. A febrile reaction (C) presents with fever and chills without urticaria. Bacterial contamination (D) causes high fever, rigors, and rapid hemodynamic collapse — not localized hives.